BRIDGEBIO PHARMA INC. - COMMON STOCK
23,42
22-ноября-24 15:44:58
15 мин. задержка
Акции
+0,18
+0,77%
Сегодняшний диапазон
22,47 - 23,65
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05 июл 2024 15:31:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 июн 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference
06 июн 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
04 июн 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
03 июн 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
24 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
15 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
14 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
13 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
02 май 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
02 май 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 апр 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
20 мар 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
05 мар 2024 22:53:56 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
04 мар 2024 15:17:36 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
04 мар 2024 01:30:00 Источник Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
22 фев 2024 06:30:00 Источник Nasdaq GlobeNewswire